Here are six notes:
1. The market will likely surpass $1.7 billion by 2022.
2. A growing geriatric population and increasing demand for minimally invasive procedures will boost market growth.
3. The knee application dominates the arthroscopy market, capturing one third of the market share through 2022.
4. The hip arthroscopy segment generates the greatest revenue behind knee, followed by spine arthroscopy.
5. Key market players include Arthrex, Stryker, CONMED, Smith & Nephew, Zimmer Biomet, Medtronic, Wright Medical Group and Richard Wolf.
6. Hospitals will continue to serve as the dominant end-user of arthroscopic devices.
More articles on devices:
OrthoPediatrics launches 24th surgical system: 3 things to know
Arthrex beings headquarter expansion, to add 500+ jobs
Zyga’s SImmetry SI Joint Fusion System clinical trial shows reduction in back pain, opioid dependency: 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
